LBRX Financial Statements From 2010 to 2026

LBRX Stock   19.06  0.73  3.69%   
LB Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing LB Pharmaceuticals' valuation are provided below:
We have found ninety-three available fundamental measures for LB Pharmaceuticals, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to check all of LB Pharmaceuticals latest market performance against the performance between 2010 and 2026 to make sure the company can sustain itself this quarter and beyond. Enterprise Value is likely to rise to about 55.8 M in 2026
Check LB Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LB Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 800, Net Interest Income of 2.1 M or Interest Income of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. LBRX financial statements analysis is a perfect complement when working with LB Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with LBRX Stock
Check out the analysis of LB Pharmaceuticals Correlation against competitors.

LB Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets36.9 M38.6 M25.5 M
Slightly volatile
Short and Long Term Debt Total3.2 M3.3 M19.3 M
Slightly volatile
Other Current Liabilities6.4 M6.1 M1.4 M
Slightly volatile
Total Current Liabilities9.8 M9.3 M2.1 M
Slightly volatile
Property Plant And Equipment NetM4.8 M824.7 K
Slightly volatile
Accounts Payable1.4 M2.7 M577.8 K
Slightly volatile
Cash21.8 M26.4 M21.4 M
Very volatile
Non Current Assets Total5.6 M5.4 M923 K
Slightly volatile
Long Term Debt19.3 M21.7 M23.7 M
Slightly volatile
Cash And Short Term Investments34 M32.2 M24.5 M
Slightly volatile
Common Stock Shares Outstanding2.8 M3.2 M3.5 M
Slightly volatile
Liabilities And Stockholders Equity36.9 M38.6 M25.5 M
Slightly volatile
Non Current Liabilities Total90.7 M138 M63.2 M
Slightly volatile
Other Current Assets1.2 MM385.5 K
Slightly volatile
Other Stockholder Equity8.2 M11.1 M6.8 M
Slightly volatile
Total Liabilities94.8 M147.3 M65 M
Slightly volatile
Property Plant And Equipment Gross5.1 M4.9 M850.6 K
Slightly volatile
Total Current Assets35.2 M33.2 M24.8 M
Slightly volatile
Capital Stock800900982
Slightly volatile
Net Working Capital22.6 M18.7 M22.3 M
Pretty Stable
Common Stock800900982
Slightly volatile
Accumulated Other Comprehensive Income154 K99.9 K247.1 K
Slightly volatile
Non Currrent Assets Other398.4 K448.2 K489.2 K
Slightly volatile
Short Term Debt389.6 K438.3 K478.4 K
Slightly volatile

LB Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision800900982
Slightly volatile
Interest Income2.1 MM443.4 K
Slightly volatile
Depreciation And Amortization109.9 K104.7 K19.7 K
Slightly volatile
Selling General Administrative16.5 M15.7 MM
Slightly volatile
Other Operating Expenses78.3 M74.6 M15.6 M
Slightly volatile
Research Development61.8 M58.8 M11.6 M
Slightly volatile
Total Operating Expenses78.3 M74.6 M15.6 M
Slightly volatile
Reconciled Depreciation109.9 K104.7 K19.7 K
Slightly volatile
Income Tax Expense800900982
Slightly volatile

LB Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation3.8 M3.6 M971.2 K
Slightly volatile
Begin Period Cash Flow13.7 M17.2 M4.8 M
Slightly volatile
Depreciation109.9 K104.7 K19.7 K
Slightly volatile
Issuance Of Capital Stock27.8 M46 M9.4 M
Slightly volatile
Total Cash From Financing Activities34.8 M44.1 M26.4 M
Slightly volatile
End Period Cash Flow21.9 M27 M21.5 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation5.887.616.4377
Slightly volatile
Cash Per Share6.987.126.6366
Slightly volatile
Income Quality0.790.760.3994
Slightly volatile
ROE0.360.60.4872
Pretty Stable
Current Ratio3.894.136.7474
Slightly volatile
Capex Per Share0.210.20.0427
Slightly volatile
Interest Debt Per Share1.141.25.9592
Slightly volatile
Debt To Assets0.120.130.8869
Slightly volatile
Ebt Per Ebit1.061.124.1237
Slightly volatile
Quick Ratio3.894.136.7474
Slightly volatile
Net Income Per E B T1.11.151.0148
Slightly volatile
Cash Ratio3.13.2635.7782
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.810.910.9861
Slightly volatile
Debt Ratio0.120.130.8869
Slightly volatile
Return On Equity0.360.60.4872
Pretty Stable

LB Pharmaceuticals Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap67.4 M70.4 M62.2 M
Slightly volatile
Enterprise Value55.8 M48.3 M60.3 M
Slightly volatile

LBRX Fundamental Market Drivers

About LB Pharmaceuticals Financial Statements

LB Pharmaceuticals investors use historical fundamental indicators, such as LB Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LB Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LBRX Stock Analysis

When running LB Pharmaceuticals' price analysis, check to measure LB Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LB Pharmaceuticals is operating at the current time. Most of LB Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of LB Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LB Pharmaceuticals' price. Additionally, you may evaluate how the addition of LB Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.